Globus Medical
GMED
303 hedge funds and large institutions have $2.95B invested in Globus Medical in 2018 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 117 increasing their positions, 100 reducing their positions, and 57 closing their positions.
114% more call options, than puts
Call options by funds: $4.48M | Put options by funds: $2.09M
17% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 100
1.68% more ownership
Funds ownership: 88.2% → 89.89% (+1.7%)
9% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 57
3% less funds holding
Funds holding: 312 → 303 (-9)
28% less capital invested
Capital invested by funds: $4.07B → $2.95B (-$1.12B)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ninety One (UK)
London,
United Kingdom
|
+$74.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$73.5M |
| 3 |
Renaissance Technologies
New York
|
+$16.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.5M |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$13.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$24M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$17.9M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$15.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.4M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$12.8M |
GMED Hedge Fund Activity: Q4 2018 in Review
303 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2018, worth a combined $2.95B — down 28% from $4.07B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of GMED and 52 opened new positions — a net loss of 5 holders — while 100 trimmed existing stakes and 117 added.
The largest buyer was Ninety One (UK), opening a new position worth an estimated $74.7M. The largest seller was Marshall Wace, cutting an estimated $24M.
- 303 institutional investors held Globus Medical (GMED) as of Q4 2018, down from 312 in Q3 2018.
- Funds reported $2.95B of Globus Medical stock for Q4 2018, down 28% quarter-over-quarter.
- 52 funds opened new Globus Medical positions in Q4 2018 and 57 closed out, a net change of -5 holders.
- The largest Globus Medical buyer in Q4 2018 was Ninety One (UK), an estimated $74.7M added.
- The largest Globus Medical seller in Q4 2018 was Marshall Wace, an estimated $24M sold.
Based on aggregated 13F filings for Q4 2018.